# Bexarotene signaling in human B and T lymphocytes induces gut-homing receptor expression

**Authors:** Sina Kaiser, Ina Suhrkamp, Jinru He, Charlotte Helf, Christian D. Sadik, Michael Weichenthal, Guido Heine

PMC · DOI: 10.3389/fimmu.2025.1664199 · Frontiers in Immunology · 2025-10-08

## TL;DR

Bexarotene affects human B and T cells by increasing gut-homing receptors and CD38, influencing immune responses and cell differentiation.

## Contribution

Bexarotene's direct impact on retinoid target gene expression and gut-homing receptor modulation in B and T lymphocytes is demonstrated.

## Key findings

- BXR increased CD38 expression sixfold in B cells and threefold in T cells.
- BXR doubled gut-homing receptors CCR9 and integrin β7 on T and B cells.
- BXR treatment reduced gut-homing receptor frequency in CTCL patient blood cells.

## Abstract

Retinoic acid (RA) receptors (RARs) in human lymphocytes modulate the humoral and intestinal immune response by regulating target genes, including CD38, TGM2, and gut-homing markers. The impact of retinoid X receptors (RXRs) on this process is elusive.

To determine the impact of the RXR ligand bexarotene (BXR) on the activation and differentiation of human B and T lymphocytes.

In vitro BXR stimulation of human CD19+ B cells and CD4+ T helper cells was investigated regarding retinoid target gene expression using qPCR and flow cytometry and validated in peripheral B and T lymphocytes of patients with cutaneous T-cell lymphoma (CTCL) with and without BXR treatment.

BXR induced the canonical retinoid target gene CD38 in B cells and T cells (sixfold and threefold, respectively). BXR increased CD38 surface protein expression on B cells twofold and plasmablast differentiation threefold. The frequency of the gut-homing receptors CCR9 and integrin β7 was doubled on T and B cells after BXR stimulation, while cutaneous leucocyte-associated antigen (CLA) expression was decreased in B cells. Under BXR treatment, a reduced frequency of cells with these gut-homing receptors was observed in the blood of CTCL patients regarding memory T cells (mean off: 1.9%; on: 0.6%) and B cells (mean off: 5.7%, on: 4%).

BXR via RXRs directly targets B and T lymphocytes, inducing retinoid target gene expression, including gut-homing receptors.

## Linked entities

- **Genes:** CD38 (CD38 molecule) [NCBI Gene 952], TGM2 (transglutaminase 2) [NCBI Gene 7052]
- **Chemicals:** bexarotene (PubChem CID 82146)
- **Diseases:** cutaneous T-cell lymphoma (MONDO:0000607)

## Full-text entities

- **Genes:** CD19 (CD19 molecule) [NCBI Gene 930] {aka B4, CVID3}, RXRA (retinoid X receptor alpha) [NCBI Gene 6256] {aka NR2B1, RXR-alpha, RXRalpha}, CD38 (CD38 molecule) [NCBI Gene 952] {aka ADPRC 1, ADPRC1, cADPR1}, SELPLG (selectin P ligand) [NCBI Gene 6404] {aka CD162, CLA, PSGL-1, PSGL1}, TGM2 (transglutaminase 2) [NCBI Gene 7052] {aka G(h), TG(C), TGC, hTG2, tTG}, CCR9 (C-C motif chemokine receptor 9) [NCBI Gene 10803] {aka CC-CKR-9, CDw199, GPR-9-6, GPR28}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, ITGB7 (integrin subunit beta 7) [NCBI Gene 3695]
- **Diseases:** CTCL (MESH:D016410)
- **Chemicals:** retinoid (MESH:D012176), BXR (MESH:D000077610)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12540313/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12540313/full.md

## References

34 references — full list in the complete paper: https://tomesphere.com/paper/PMC12540313/full.md

---
Source: https://tomesphere.com/paper/PMC12540313